glp 1 based therapeutics summit GLP-1-Based on April 14-16, 2026 in Boston, United States GLP-1-Based Therapeutics Summit | Philadelphia,

Ro recently published the first study to evaluate both the long-term weight loss and safety outcomes of treatment with semaglutide via telehealth

E.McNultyS

ZO-1, a key tight junction protein, was severely damaged in the RT group, while the EGCG-Zn group significantly restored ZO-1 continuity (Figs

This article explores how physicians are actively debating how to maximize the benefits of GLP-1s while mitigating the risks, sharing clinical observations and crowdsourcing best practices for patient care

A total of four sessions, delivered twice a week for two weeks, achieves optimal results

Fasano, C., Disciglio, V., Bertora, S., Lepore Signorile, M